Collagen promotes anti-PD-1/PD-L1 resistance in cancer through LAIR1-dependent CD8+ T cell exhaustion | Nature Communications
Discovery of low-molecular weight anti-PD-L1 peptides for cancer immunotherapy | Journal for ImmunoTherapy of Cancer | Full Text
PD-1/PD-L1 interaction blocked by antibodies, freeing T cell to kill tumor cell - FineTest ELISA Kit | FineTest Antibody | Wuhan Fine Biotech Co., Ltd.
PD-1 (EH33) Mouse mAb (IHC-Specific) | Cell Signaling Technology
Bio X Cell - InVivoMAb anti-mouse PD-1 (CD279)
A. C57BL/6 mice were intraperitoneally treated with an anti-PD-1... | Download Scientific Diagram
Anti-PD-1 Blocking Antibody Inhibits Human Melanoma Xenograft Growth in... | Download Scientific Diagram
Anti-PD-1 Antibody Therapy Potently Enhances the Eradication of Established Tumors By Gene-Modified T Cells | Clinical Cancer Research
Engineering high-affinity PD-1 variants for optimized immunotherapy and immuno-PET imaging | PNAS
Bio X Cell - PD1 Antibodies
PD‐1‐specific “Blocking” antibodies that deplete PD‐1+ T cells present an inconvenient variable in preclinical immunotherapy experiments - Polesso - 2021 - European Journal of Immunology - Wiley Online Library
PD-L1 on dendritic cells attenuates T cell activation and regulates response to immune checkpoint blockade | Nature Communications
A human programmed death-ligand 1-expressing mouse tumor model for evaluating the therapeutic efficacy of anti-human PD-L1 antibodies | Scientific Reports
Anti-PD-1 antibody decreases tumour-infiltrating regulatory T cells | BMC Cancer | Full Text
Combined immunotherapy with anti-PDL-1/PD-1 and anti-CD4 antibodies cures syngeneic disseminated neuroblastoma | Scientific Reports
Mouse PD-L1 Antibody AF1019: R&D Systems
FcγRs Modulate the Anti-tumor Activity of Antibodies Targeting the PD-1/PD- L1 Axis: Cancer Cell
PD-L1 (D5V3B) Rabbit mAb (Mouse Specific; IHC Specific) | Cell Signaling Technology
Targeted delivery of a PD-1-blocking scFv by CAR-T cells enhances anti-tumor efficacy in vivo | Nature Biotechnology
The FG Loop of PD-1 Serves as a “Hotspot” for Therapeutic Monoclonal Antibodies in Tumor Immune Checkpoint Therapy - ScienceDirect
Human PD-1 Antibody (PD1.D3), mAb, Mouse - GenScript
Anti-PD-L1 mIgG1e3 monoclonal antibody | Atezolizumab-based
TLR4 signaling improves PD-1 blockade therapy during chronic viral infection
PD-L1 Neutralizing Antibody
